VERTANICAL has announced a significant milestone in its development of VER-01, an investigational non-opioid therapeutic candidate for chronic low back…
Read More

VERTANICAL has announced a significant milestone in its development of VER-01, an investigational non-opioid therapeutic candidate for chronic low back…
Read More
Telomir Pharmaceuticals has taken a significant stride in its mission to combat advanced and metastatic triple-negative breast cancer (TNBC) by…
Read More